Clinical Trials Directory

Trials / Completed

CompletedNCT02890979

Swallowable Sponge Cell Sampling Device and Next Generation Sequencing in Detecting Esophageal Cancer in Patients With Low or High Grade Dysplasia, Barrett Esophagus, or Gastroesophageal Reflux Disease

Next Generation Sequencing of Esophageal Cytology for the Early Detection of Esophageal Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
OHSU Knight Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This pilot clinical trial studies how well a swallowable sponge cell sampling device and next generation sequencing work in detecting esophageal cancer in patients with low or high grade dysplasia, Barrett esophagus, or gastroesophageal reflux disease. Checking biomarkers in abnormal esophageal cells using a swallowable sponge cell sampling device and next generation sequencing may improve diagnosis and treatment of esophageal cancer.

Detailed description

PRIMARY OBJECTIVES: I. Determine the sensitivity and specificity of next generation sequencing for the detection of esophageal cancer from esophageal sponge cytology specimens. SECONDARY OBJECTIVES: I. Determine the ability of next generation gene sequencing (NGS) of esophageal sponge samples to collect an adequate sample to detect mutations that are present in the underlying tissue. II. Determine the cost associated with esophageal cytology with next generation genome sequencing as a screening tool. III. Continue to collect safety and tolerability data related to the use of the Oesotest esophageal sponge. IV. Determine the limitations of esophageal sponge cytology and future needs to improve this technique. V. Use the data collected to design a larger screening trial to determine the ability of esophageal cytology with next generation sequencing to screen for esophageal cancer in the general population. OUTLINE: Patients undergo cytology specimen collection procedure using a swallowable sponge cell sampling device.

Conditions

Interventions

TypeNameDescription
OTHERCytology Specimen Collection ProcedureUndergo cytology specimen collection procedure using a swallowable sponge cell sampling device
OTHERLaboratory Biomarker AnalysisCorrelative studies
OTHERQuality-of-Life AssessmentAncillary studies
DEVICESwallowable Sponge Cell Sampling DeviceUndergo cytology specimen collection procedure using a swallowable sponge cell sampling device

Timeline

Start date
2016-08-03
Primary completion
2017-10-10
Completion
2017-10-10
First posted
2016-09-07
Last updated
2020-11-25

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT02890979. Inclusion in this directory is not an endorsement.